The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism (Q36972684): Difference between revisions
Jump to navigation
Jump to search
Updated Item: Updating citation graph |
Updated Item: Removing the trailing dot from the label |
||
label / en | label / en | ||
The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism | The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism |
Revision as of 16:04, 10 April 2018
scientific article published on 05 June 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism |
scientific article published on 05 June 2008 |
Statements
1 reference
The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism. (English)
1 reference
Tommaso Angelone
1 reference
Anna Maria Quintieri
1 reference
Bhawanjit K Brar
1 reference
Pauline T Limchaiyawat
1 reference
Bruno Tota
1 reference
Sushil K Mahata
1 reference
Maria Carmela Cerra
1 reference
5 June 2008
1 reference
1 reference
4780-4793
1 reference
Identifiers
1 reference
1 reference
1 reference